ESR1 and breast cancer: Compounds bearing m-F, m-CH3 and m-CF3/p-Cl showed also antitumor potential against two different human breast cancer cell lines, MCF-7 (Estrogen receptor positive, ER+) and MDA-MB-231 (TNBC).